| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 8.1e-05 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 6.9e-05 | 1 |